美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cerenome, Inc

3.21

-0.4738-12.88%

成交量：15.83萬

成交額：50.07萬

市值：2,200.09萬

市盈率：-1.23

高：3.50

開：3.43

低：3.00

收：3.68

52周最高：23.43

52周最低：2.90

股本：686.20萬

流通股本：633.95萬

量比：7.74

換手率：2.50%

股息：- -

股息率：- -

每股收益(TTM):-2.6163

每股收益(LYR):-7.2500

淨資產收益率：-614.05%

總資產收益率：-135.36%

市淨率：4.03

市盈率(LYR):-0.44

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Cerenome, Inc

交易所：

NASDAQ

成立時間：

1996

員工人數：

28

公司地址：

6420 Levit Green Blvd,Suite 210,Houston,Texas,United States

官網：

http://www.plustherapeutics.com

郵編：

77021

電話：

傳真：

210 974 6901

簡介：

Cerenome, Inc.最初於1996年7月成立為加利福尼亞州普通合夥企業，並於1997年5月在特拉華州註冊成立。該公司是一家美國醫療保健公司，致力於開發和商業化用於中樞神經系統（“CNS”）癌症的精確診斷和靶向放射性藥物。CNSide Diagnostics, LLC是其全資子公司，開發和商業化專有實驗室開發的測試，如CNSide，旨在識別癌症和黑色素瘤患者中轉移到中樞神經系統的腫瘤細胞。

董事

名稱

職位

Marc H. Hedrick

President, Chief Executive Officer and Director

Richard J. Hawkins

Chairman of the Board

An van Es Johansson

Director

Howard Clowes

Director

Kyle Guse Esq

Director

Robert Lenk

Director

股東

名稱

職位

Marc H. Hedrick

President, Chief Executive Officer and Director

Andrew Sims

Chief Financial Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/CNSY/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNSY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","market":"US","secType":"STK","nameCN":"Cerenome, Inc","latestPrice":3.2062,"timestamp":1786980189263,"preClose":3.68,"halted":0,"volume":158326,"delay":0,"changeRate":-0.12875000000000006,"floatShares":6339500,"shares":6862000,"eps":-2.616304,"marketStatus":"交易中","change":-0.4738,"latestTime":"08-17 11:24:00 EDT","open":3.43,"high":3.5,"low":3,"amount":500675.9563904,"amplitude":0.13587,"askPrice":3.21,"askSize":100,"bidPrice":3.15,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-2.616304,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":3.68,"preHourTrading":{"tag":"盘前","latestPrice":3.49,"preClose":3.68,"latestTime":"09:29 EDT","volume":4492,"amount":14935.4481048,"timestamp":1786973345436,"change":-0.19,"changeRate":-0.05163,"amplitude":0.046196},"postHourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.68,"latestTime":"19:50 EDT","volume":20364,"amount":68714.4463,"timestamp":1786751434052,"change":-0.41,"changeRate":-0.111413,"amplitude":0.127717},"volumeRatio":7.74239},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","floatShares":6339500,"roa":"-135.36%","roe":"-614.05%","lyrEps":-7.25,"volumeRatio":7.74239,"shares":6862000,"dividePrice":0,"high":3.5,"amplitude":0.13587,"preClose":3.68,"low":3,"week52Low":2.9,"pbRate":"4.03","psRate":"5.23","week52High":23.425,"institutionHeld":0,"latestPrice":3.2062,"committee":-0.834862,"eps":-2.616304,"divideRate":0,"volume":158326,"delay":0,"ttmEps":-2.616304,"open":3.43,"prevYearClose":12.8075,"prevWeekClose":3.68,"prevMonthClose":3.87,"prevQuarterClose":4.37,"fiveDayClose":3.84,"twentyDayClose":3.83,"sixtyDayClose":6.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNSY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNSY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNSY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNSY","date":"2026-08-14","current":-1.249855,"percent":0.777778,"low":-2.284561,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"high":-2.030721,"avg":-2.193409,"sd":0.070175,"marketCap":25467492},"quantilePoints":[{"date":"2026-08-07","current":-2.22687,"twenty":-2.261485,"median":-2.232639,"eighty":-2.18764,"marketCap":26568789},{"date":"2026-08-14","current":-2.134565,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"marketCap":25467492}],"updateTime":1786977406524},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":264193,"yearFounded":1996,"employeeNum":28,"address":"6420 Levit Green Blvd,Suite 210,Houston,Texas,United States","zipCode":"77021","officePhone":"210 974 6900","officeFax":"210 974 6901","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.plustherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0392},{"period":"1month","weight":-0.098},{"period":"3month","weight":-0.299},{"period":"6month","weight":-0.4651},{"period":"1year","weight":-0.7285},{"period":"ytd","weight":-0.7127}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cerenome, Inc.最初於1996年7月成立為加利福尼亞州普通合夥企業，並於1997年5月在特拉華州註冊成立。該公司是一家美國醫療保健公司，致力於開發和商業化用於中樞神經系統（“CNS”）癌症的精確診斷和靶向放射性藥物。CNSide Diagnostics, LLC是其全資子公司，開發和商業化專有實驗室開發的測試，如CNSide，旨在識別癌症和黑色素瘤患者中轉移到中樞神經系統的腫瘤細胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.059718},{"month":2,"riseRate":0.541667,"avgChangeRate":0.032207},{"month":3,"riseRate":0.375,"avgChangeRate":-0.062118},{"month":4,"riseRate":0.375,"avgChangeRate":-0.005258},{"month":5,"riseRate":0.458333,"avgChangeRate":0.34396},{"month":6,"riseRate":0.24,"avgChangeRate":-0.083556},{"month":7,"riseRate":0.4,"avgChangeRate":-0.008304},{"month":8,"riseRate":0.28,"avgChangeRate":-0.042043},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.030103},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.062759},{"month":11,"riseRate":0.375,"avgChangeRate":0.007725},{"month":12,"riseRate":0.375,"avgChangeRate":-0.028095}],"exchange":"NASDAQ","name":"Cerenome, Inc","nameEN":"Cerenome, Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":{"directors":[{"name":"Marc H. Hedrick","position":"President, Chief Executive Officer and Director"},{"name":"Richard J. Hawkins","position":"Chairman of the Board"},{"name":"An van Es Johansson","position":"Director"},{"name":"Howard Clowes","position":"Director"},{"name":"Kyle Guse Esq","position":"Director"},{"name":"Robert Lenk","position":"Director"}],"executives":[{"name":"Marc H. Hedrick","position":"President, Chief Executive Officer and Director"},{"name":"Andrew Sims","position":"Chief Financial Officer"}]}}}